2025年青蒿琥酯最新价格是多少钱一盒？

Artesunate is an antimalarial drug independently developed by China. Since its launch in 1987, it has become an important drug in the global fight against malaria. In 2025, the price, global launch status and drug preparation of artesunate will be the focus of attention of patients and medical workers. This article will start from these three aspects, analyze the latest developments of artesunate in detail, and help readers fully understand the current situation of this drug.

How much is the latest price of artesunate per box in 2025

The price of artesunate will be adjusted in 2025, mainly affected by production costs, market demand and medical insurance policies.

Price Reference

The specification of artesunate is 50mg*4 capsules/box, and the price is about US$21 per box. This price is competitive globally, especially for developing countries in areas with high malaria prevalence.

Medical insurance reimbursement ratio

Artesunate has been included in China’s medical insurance as a Class B drug. The reimbursement ratio varies by region and policy. The support of medical insurance policies has significantly reduced the financial burden of patients and improved the accessibility of the drug.

The impact of generic drugs

There are already generic drugs of artesunate on the market, and the price is lower than the original drug. The emergence of generic drugs has further promoted the popularity of drugs, but patients need to pay attention to the quality and efficacy of the drugs when choosing.

The price of artesunate will remain stable in 2025, and the promotion of medical insurance and generic drugs will provide treatment opportunities for more patients.

Global marketing status of artesunate

Since its launch in China in 1987, artesunate has gradually gone global and has become one of the basic antimalarial drugs recommended by the World Health Organization.

Main listing countries and regions

Artesunate has been launched in many countries and regions such as the European Union, the United Kingdom, and the United States. In May 2020, it was approved by the US FDA, further expanding the global market.

Recommendation by the World Health Organization

In 2000, artesunate was listed as an essential antimalarial drug by the World Health Organization. Its high efficiency and safety make it one of the drugs of choice for antimalarial treatment worldwide.

Global distribution of generic drugs

In addition to the original drugs, generic drugs of artesunate are also on the market in many countries, especially in Africa and Southeast Asia, where malaria is high. The expansion of generic drugs provides treatment options for more patients.

The global listing of artesunate reflects its important position in the anti-malarial field, and it is expected to further expand market coverage in the future.

Preparation for the administration of artesunate

The administration of artesunate needs to be strictly followed.

Preparation method

Each bottle of 110mg artesunate powder needs to be dissolved in 11mL of the included 12mL sterile phosphate buffer, and gently swirled for 5-6 minutes until completely dissolved. The solution must be used within 1.5 hours after preparation.

Usage and Dosage

The recommended dose for adults and children is 2.4 mg/kg, intravenously. The initial dose is administered at 0 hour, 12 hours, and 24 hours, and then once daily until the patient can tolerate oral antimalarial drugs.

Adverse reaction monitoring

After taking the drug, hemoglobin, haptoglobin and other indicators need to be closely monitored to be wary of delayed hemolysis and allergic reactions. If any abnormality occurs, the medication must be stopped immediately and corresponding measures must be taken.

The drug preparation of artesunate needs to strictly follow the specifications, and careful operation is required from preparation to monitoring.